FDA Inspection
Lexington Medical CenterLexington Medical Center – FDA Inspection, Oct 30, 2024
Record Details
This FDA Inspection record concerns Lexington Medical Center, with an inspection on October 30, 2024, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 86e7a9d1-971c-4a6f-814f-d3a8395f6c6f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1253271
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.151(e)Procedures to maintain records of emergency transfusions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lexington Medical Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2020 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 10, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 13, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 16, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Lexington Medical Center
- FDA Inspection 1115175 - 2020-01-15
- FDA Inspection 1038773 - 2018-01-10
- FDA Inspection 957156 - 2016-01-21
- FDA Inspection 884380 - 2014-06-13
- FDA Inspection 774594 - 2012-02-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.